Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy

Abstract

The efficacy of first-line chemoradiotherapy for overall survival (OS) might be confounded by the subsequent treatments in patients with locally advanced non-small cell lung cancer (NSCLC). In this study, we assessed the associations of progression-free survival (PFS) and post-progression survival (PPS) with OS after chemoradiotherapy for locally advanced NSCLC using patient-level data.

Keywords

• chemoradiotherapy
• glasgow prognostic score
• locally advanced non-small cell lung cancer
• overall survival
• post-progression survival
• progression-free survival